Portfolio Update - replacement

RNS Number : 5555M

Intl. Biotechnology Trust PLC

30 April 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Amendments to the Top Ten Quoted Investments have been made to the 'Portfolio Update' announcement released on Friday, 27 April 2018 at 12:58 under RNS No 4257M.

All other details remain unchanged.

The full amended text is shown below.

Portfolio Update as at 31 March 2018

Net Assets	£219m
Net Assets per share	584p
Share price	548p
Total value of unquoted investments	£21m
Total number of portfolio companies	90
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	6.0
Shire	4.8
Array	4.5
Neurocrine	4.2
Biogen	4.1
Regeneron	4.0
Genmab	3.9
Sage	3.7
Vertex	3.6
Gilead	3.2
	-----------
Total	42.0

Geographical Allocation	% NAV
US & Canada	83
Europe & UK	17
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	36
Mid Cap =USD1-10BN	37
Small Cap <USD1BN	27
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	42
CNS	18
Rare diseases	11
Inflammation	7
Ophthalmology	6
Infectious Diseases	4
Metabolic	3
Medtech	3
Other	6
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

30 APRIL 2018

 

END

 

 

PFUIMMLTMBTJMJP